Cold atmospheric pressure plasma: A potential physical therapy for rheumatoid arthritis hyperplastic synovium

Int Immunopharmacol. 2023 Oct:123:110732. doi: 10.1016/j.intimp.2023.110732. Epub 2023 Jul 31.

Abstract

The most significant pathological change in rheumatoid arthritis (RA) is synovial hyperplasia within the joint. The production of a series of degrading enzymes and oxidative stress caused by synovial hyperplasia lead to severe bone and cartilage damage in rheumatoid joints. The core effector cell in hyperplastic synovium is fibroblast-like synovium cells, which can invade cartilage, cause inflammation, destroy joints, and show tumor-like anti-apoptosis characteristics. This study focused on the effect of cold atmospheric pressure plasma on proliferative synovium, and the results showed that no synovial hyperplasia, angiogenesis, or inflammatory infiltration was observed after cold atmospheric pressure plasma (CAP) treatment. The molecular and cellular mechanisms also reveal the spontaneous reactive oxygen species (ROS) cascade inducing apoptosis in rheumatoid arthritis fibroblast-like synoviocytes (RA-FLS) cells. This study proposes a potential physical therapy method for treating proliferative synovium and also provides ideas for the application of CAP in other types of tumor diseases.

MeSH terms

  • Arthritis, Rheumatoid* / metabolism
  • Fibroblasts / metabolism
  • Humans
  • Hyperplasia / metabolism
  • Physical Therapy Modalities / adverse effects
  • Synovial Membrane / pathology
  • Synoviocytes*